Lurasidone metabolite 14326
Lurasidone metabolite 14326 is a minor active metabolite of Lurasidone (HY-B0032A) generated via metabolism by CYP3A4. Lurasidone metabolite 14326 shares similar receptor-binding properties with Lurasidone, acting as an antagonist of the dopamine D2 receptor (dopamine D2 receptor), an antagonist of the serotonin 5-HT2A and 5-HT7 receptors (5-HT2A and 5-HT7 receptor), and a partial agonist of the serotonin 5-HT1A receptor. Lurasidone metabolite 14326 can be used in the research of schizophrenia and bipolar depression.
For research use only. We do not sell to patients.
- CAS No.: 186204-33-1
- Formula: C28H36N4O3S
- Molecular Weight:508.68
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
D2 Receptor |
5-HT2A Receptor |
5-HT7 Receptor |
5-HT1A Receptor |
Lurasidone metabolite 14326 exhibits receptor-binding pharmacodynamic activity similar to that of Lurasidone in assays using rat, guinea pig and human recombinant cell receptors, but its exposure (concentration) in humans is extremely low[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 186204-33-1
-
Molecular Weight 508.68
-
Formula C28H36N4O3S
-
SMILES
O=C([C@]([C@@H]1C[C@H](O)[C@H]2C1)([H])[C@]2([H])C3=O)N3C[C@H]4[C@H](CN(CC5)CCN5C6=NSC7=C6C=CC=C7)CCCC4
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)